Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trial.
Tang Y, Xing Y, Sun L, Wang Z, Wang C, Yang K, Zhu W, Shi X, Xie B, Yin Y, Mi Y, Wei T, Tong R, Qiao Y, Yan S, Wei P, Yang Y, Shan Y, Zhang X, Jia J, Teipel SJ, Howard R, Lu J, Li C, Zhao G. Tang Y, et al. Alzheimers Res Ther. 2024 Sep 12;16(1):203. doi: 10.1186/s13195-024-01570-0. Alzheimers Res Ther. 2024. PMID: 39267112 Free PMC article. Clinical Trial.
[Chinese expert consensus on digital therapeutics for cognitive impairment (2023 edition)].
Chinese Society of Dementia and Cognitive Impairment; Consensus Panel on Digital Therapeutics for Cognitive Impairment. Chinese Society of Dementia and Cognitive Impairment, et al. Zhonghua Yi Xue Za Zhi. 2023 Mar 7;103(9):640-647. doi: 10.3760/cma.j.cn112137-20221121-02441. Zhonghua Yi Xue Za Zhi. 2023. PMID: 36858363 Chinese.
[Chinese guideline for clinical application of fluid biomarkers for Alzheimer's disease(2024 edition)].
National Health Commission Capacity Building and Continuing Education Center; Chinese Neuroscience Society; Aging Biomarker Consortium; Writing Group for the Chinese Guideline for Clinical Application of Fluid Biomarkers for Alzheimer′s Disease. National Health Commission Capacity Building and Continuing Education Center, et al. Zhonghua Yi Xue Za Zhi. 2024 Sep 10;104(35):3292-3306. doi: 10.3760/cma.j.cn112137-20240523-01174. Zhonghua Yi Xue Za Zhi. 2024. PMID: 39266494 Chinese.
[Blue paper on Alzheimer's disease in China(simplified version)].
National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University; National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention; National Health Commission Capacity Building and Continuing Education Center; China Population and Development Research Center; Project Group of "Blue Paper on Alzheimer′s Disease in China ". National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, et al. Zhonghua Yi Xue Za Zhi. 2024 Jul 30;104(29):2701-2727. doi: 10.3760/cma.j.cn12137-20240416-00883. Zhonghua Yi Xue Za Zhi. 2024. PMID: 38783696 Chinese.